Chloroquine: Uses, Dosage, Side Effects & Safety Tips

Introduction

Chloroquine is a synthetic antimalarial drug widely used for the treatment and prevention of malaria, a life-threatening disease caused by the Plasmodium parasite. Originally derived from quinine, chloroquine has been a cornerstone in the fight against malaria for decades. It is known for its effectiveness against several strains of the malaria parasite, including Plasmodium vivax, P. malariae, P. ovale, and some strains of P. falciparum.

Uses and Indications

Chloroquine is primarily used for the following purposes:

• Treatment of acute, uncomplicated malaria caused by susceptible strains of Plasmodium species ^[1]
• Prophylaxis (prevention) of malaria in geographic areas where chloroquine-resistant strains are not prevalent ^[2]
• Off-label uses: Treatment of certain inflammatory diseases and autoimmune conditions, such as rheumatoid arthritis and lupus erythematosus ^[3]

Dosage and Administration

The dosage of chloroquine varies depending on the purpose of use and the patient’s age, weight, and overall health condition. Here are some general guidelines:

Treatment of Malaria

• Adults: 600 mg (base) initially, followed by 300 mg (base) 6-8 hours later, then 300 mg (base) once a day on the next two days
• Children: 10 mg (base) per kg of body weight, divided into three doses as for adults

Prevention of Malaria

• Adults: 500 mg (base) once a week, starting 1-2 weeks before travel and continuing for 4 weeks after leaving the endemic area
• Children: 5 mg (base) per kg of body weight once a week, with the same timing as adults

Side Effects and Adverse Reactions

Like any medication, chloroquine can cause side effects. Common side effects include:

• Nausea, vomiting, diarrhea, abdominal cramps
• Headache, dizziness
• Blurred vision, eye problems (rare with short-term use)
• Skin rash, hair loss (temporary)

More serious adverse reactions, though rare, may include:

• Irreversible retinal damage (with long-term or high-dosage use)
• Cardiac conduction disorders (e.g., QT prolongation, arrhythmias)
• Hypoglycemia (low blood sugar)
• Blood disorders (e.g., aplastic anemia, agranulocytosis)

Special Precautions and Contraindications

Chloroquine should be used with caution or avoided in certa in situations, including:

• Pregnancy and breastfeeding: Potential risks to the fetus or infant should be considered.
• Liver or kidney disease: Dosage adjustment may be necessary.
• Retinal or visual field changes: Long-term use requires regular eye examinations.
• Glucose-6-phosphate dehydrogenase (G6PD) deficiency: Increased risk of hemolytic anemia.
• Allergies or hypersensitivity to chloroquine or related drugs (e.g., quinidine, quinine).

Drug Interactions

Chloroquine can interact with various medications, potentially altering their effectiveness or causing adverse effects. Some notable interactions include:

• Antacids and kaolin: Reduced absorption of chloroquine
• Cimetidine: Increased plasma levels of chloroquine
• Cyclosporine: Increased risk of toxic effects from chloroquine
• Digoxin: Potential for increased digoxin levels
• Neostigmine and pyridostigmine: Possible antagonism of antimalarial effect

armacology”>

armacology/”>Ph armacology and Mechanism of Action

Chloroquine is a 4-aminoquinoline compound with antimalarial properties. It acts by interfering with the ability of the Plasmodium parasite to digest and detoxify heme, a byproduct of hemoglobin metabolism. This leads to the accumulation of toxic heme within the parasite, ultimately causing its death. ^[4]

Chloroquine is rapidly absorbed from the gastrointestinal tract and widely distributed throughout the body. It has a large volume of distribution and undergoes metabolic transformation in the liver, with a long terminal elimination half-life.

Resistance and Efficacy

Over time, resistance to chloroquine has emerged in various regions, primarily due to mutations in the Plasmodium parasite. Chloroquine resistance is a significant concern and has led to decreased efficacy in many areas, particularly for P. falciparum malaria. ^[5]

To combat resistance, combination therapies with other antimalarial drugs (e.g., artemisinin-based therapies) are often recommended, and regular surveillance of resistance patterns is crucial. Alternative antimalarial medications may be required in areas with high levels of chloroquine resistance.

Additional Resources

• Chloroquine.pdf” target=”_blank”>CDC Fact Sheet on Chloroquine
• FDA-Approved Prescribing Information for Chloroquine
• WHO Guidelines for the Treatment of Malaria